Zaremba Rabourn Amy 4
4 · Ocuphire Pharma, Inc. · Filed Jan 12, 2024
Insider Transaction Report
Form 4
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
- Tax Payment
Common Stock
2024-01-10$3.27/sh−3,950$12,897→ 42,658 total
4 · Ocuphire Pharma, Inc. · Filed Jan 12, 2024
Common Stock